FILTER
FILTERED INTERVIEW RESULTS
Swapan Bhattacharya
MANAGING DIRECTOR, TCG LIFESCIENCES
TCG Lifesciences explains its discovery engine aimed to build out a large portfolio of new chemical entities that can one day become marketed drugs
Rich Christie
CHIEF MEDICAL OFFICER, AICURE
Aicure explains how Artificial Intelligence and virtual communications with patients can make healthcare more effective.
Steve Tallant
DIRECTOR, MARKET DEVELOPMENT, MARKEM-IMAJE
Systech helps pharma companies with serialization and compliance with DSCSA.
Paul Smaltz
VP GLOBAL BUSINESS UNIT PHARMACEUTICALS, ROQUETTE
Roquette describes how it is expanding in the US.
Jonathan Evans
PRESIDENT & CEO, LITHIUM AMERICAS
Lithium Americas is an advanced stage developer focused on bringing lithium projects to production.
Trevor Martin
CO-FOUNDER & CEO, MAMMOTH BIOSCIENCES
"Ultimately, we aim to fine-tune this foundational technology that can be applied to innumerable challenges across a variety of industries, making biology become more like software and programming."
Alan Petro
CEO, NEW VISION PHARMACEUTICALS
"We had a client approach us to work on a rapid Covid test, wanting to produce a single-use vial for at-home testing. It was only six weeks between when we had our initial discussion to when we had produced the product for them."
Lars Schneider
PRESIDENT OF BRENNTAG SPECIALTIES, AMERICAS– BRENNTAG NORTH AMERICA, INC
"Project Brenntag and our supply chain capabilities have certainly supported us, providing a clear focus between our different businesses and specializations to grow in the pharma and life science markets."
Donna LaVoie
PRESIDENT & CEO, LAVOIEHEALTHSCIENCE
"The surge of communication need has increased exponentially as companies recognize the necessity of conveying a differentiated story amid the unprecedented number of financings and IPOs over the last two years."
Lori Hu
MANAGING DIRECTOR, VERTEX VENTURES HC
"The M&A market has been relatively slow over the past year as pharma executives wait on the sidelines for the valuation correction to play out, but I believe that we will see M&A activities increase in this coming year."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
